iRhythm Technologies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IRTC research report →
Range $150 – $255
Price Chart
About the company
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system.
- CEO
- Quentin S. Blackford
- IPO
- 2016
- Employees
- 2,400
- HQ
- San Francisco, CA, US
Get TickerSpark's AI analysis on IRTC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.59B
- P/E
- -126.98
- Fwd P/E
- 98.82
- PEG
- -0.89
- P/S
- 4.55
- P/B
- 22.02
- EV/EBITDA
- 323.73
- Div Yield
- 0.00%
- Gross Margin
- 71.00%
- Op Margin
- -2.74%
- Net Margin
- -3.53%
- ROE
- -20.60%
- ROIC
- -2.43%
Latest fiscal year · YoY change
- Revenue
- $747.14M+26.2%
- Gross Profit
- $527.25M+29.4%
- Op Income
- $-36,810,000
- Net Income
- $-44,551,000+60.7%
- EPS
- $-1.39+61.7%
- OCF Growth
- +2285.3%
- FCF Growth
- +213.0%
- 52W High
- $212.00
- 52W Low
- $100.85
- 50D MA
- $113.49
- 200D MA
- $143.17
- Beta
- 1.27
- RSI (14)
- 43
- Avg Volume
- 577.84K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the IRTC Q1 '26 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 93.7%
- Shares Outstanding
- 32.86M
- Float Shares
- 30.79M
of shares held by institutions
315 13F filers
Buy/sell ratio 1.14. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for IRTC, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Richard BlumenthalSenate · CT | Sell | Aug 14, 25 | Filing → |
| Richard BlumenthalSenate · CT | Sell | Aug 14, 25 | Filing → |
| Richard BlumenthalSenate · CT | Sell | Aug 14, 25 | Filing → |
| Richard BlumenthalSenate · CT | Sell | Aug 14, 25 | Filing → |
| Richard BlumenthalSenate · CT | Sell | Aug 14, 25 | Filing → |
| Donna ShalalaHouse · FL27 | Sell | Jun 24, 19 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Tudor Investment Corp Et Al | 20.00M | ▲ 20.00M |
| Vanguard Group Inc | 3.31M | ▲ 70.42K |
| Blackrock, Inc. | 2.74M | ▼ 72.48K |
| Rtw Investments, LP | 1.67M | ▲ 486.51K |
| Millennium Management LLC | 1.61M | ▲ 781.64K |
| Artisan Partners Limited Partnership | 1.45M | ▼ 61.09K |
| Fmr LLC | 1.36M | ▲ 733.15K |
| Holocene Advisors, LP | 1.25M | ▲ 565.09K |
| Ubs Asset Management Americas Inc | 1.05M | ▲ 217.59K |
| Geode Capital Management, LLC | 817.11K | ▼ 41.30K |
| State Street Corp | 788.30K | ▲ 23.46K |
| Bnp Paribas Asset Management Holding S.A. | 762.06K | ▲ 179.05K |
Held by 286 ETFs
Biggest fund positions in IRTC by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 2, 26 | Turakhia Minang | sell | 1,423 |
| Jul 2, 26 | Freeman Sean Clinton | sell | 918 |
| May 29, 26 | Turakhia Minang | other | 137 |
| May 29, 26 | Patterson Chad | other | 177 |
| May 29, 26 | Freeman Sean Clinton | other | 273 |
| May 29, 26 | Blackford Quentin S. | other | 178 |
| May 27, 26 | Bairey Merz Cathleen Noel | other | 1,573 |
| May 27, 26 | Bodaken Bruce G. | other | 1,573 |
| May 27, 26 | Ling Karen | other | 1,573 |
| May 27, 26 | MCGINNIS KAREN K | other | 1,573 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our IRTC coverage
Recent articles, reports, and earnings notes.
No research on IRTC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IRTC report →iRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026
globenewswire.com · Jul 16
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com · Jul 3
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
prnewswire.com · Jul 2
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
globenewswire.com · Jun 30
iRhythm discloses cyber incident, says no impact on device systems, patient safety
reuters.com · Jun 15
iRhythm Holdings to Participate in Upcoming Investor Conferences
globenewswire.com · May 19
iRhythm Technologies Touts Medicare Win, Zio Growth and AI-Driven Margin Gains
marketbeat.com · May 18
iRhythm Holdings, Inc. (IRTC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
seekingalpha.com · May 13
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
Bullish or bearish?
Where do you stand on IRTC?